In 2023, Germany led in Renin-Angiotensin System medicine use, with 415.9 DDD per thousand persons daily, followed by Finland at 292.7. Croatia saw a significant increase of 18.21% year-on-year, while Slovenia and Greece experienced decreases of 1.42% and 1.12%, respectively. South Korea saw the highest growth rate at 4.55%, despite having the lowest usage among the countries listed. Over the last five years, Germany and Finland showed modest year-on-year increases, while New Zealand's usage remained stable.
Future trends to watch include the impact of aging populations on medicine demand in Europe and innovations in hypertension treatments that could alter usage patterns. Additionally, economic shifts may affect healthcare spending, influencing use across different regions.
Top countries in Renin-Angiotensin System Medicine Use by Country
| # | 10 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 415.9 | 2023 | +2.26% | +3.08% | View data |
| 2 | 2 Finland | 292.7 | 2023 | +1.99% | +2.96% | View data |
| 3 | 3 Croatia | 239.8 | 2023 | +4.13% | +18.21% | View data |
| 4 | 4 Slovenia | 230.3 | 2023 | -0.9% | -1.42% | View data |
| 5 | 5 Italy | 222.4 | 2023 | +1.04% | +0.14% | View data |
| 6 | 6 Sweden | 208.8 | 2023 | +1.85% | +2.68% | View data |
| 7 | 7 Spain | 192 | 2023 | +1% | +1% | View data |
| 8 | 8 Greece | 162.2 | 2023 | -1.4% | -1.12% | View data |
| 9 | 9 New Zealand | 145.6 | 2023 | +4.15% | View data | |
| 10 | 10 Austria | 139.8 | 2023 | -0.57% | -0.4% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
